FORALUMAB Drug Record

  • FORALUMAB chembl:CHEMBL1743020

    Alternate Names:

    NI-0401
    FORALUMAB

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antiinflammatory agent,for treatment of Chron's disease
    (0 More Sources)

    Publications:

  • FORALUMAB   CD3D

    Interaction Score: 5.89

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name NI-0401
    Novel drug target Established target
    Mechanism of Interaction T cell surface glycoprotein CD3 inhibitor

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • FORALUMAB   CD3E

    Interaction Score: 4.12

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name NI-0401
    Novel drug target Established target
    Mechanism of Interaction T cell surface glycoprotein CD3 inhibitor

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • FORALUMAB   CD3G

    Interaction Score: 3.17

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name NI-0401
    Novel drug target Established target
    Mechanism of Interaction T cell surface glycoprotein CD3 inhibitor

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • TdgClinicalTrial: NI-0401

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,for treatment of Chron's disease
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TTD: NI-0401

    • Version: 2020.06.01

    Alternate Names:
    D0R8LV TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1743020

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL2109252

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: